These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17316825)

  • 1. DST non-suppression predicts suicide after attempted suicide.
    Jokinen J; Carlborg A; Mårtensson B; Forslund K; Nordström AL; Nordström P
    Psychiatry Res; 2007 Apr; 150(3):297-303. PubMed ID: 17316825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients.
    Jokinen J; Nordström P
    J Affect Disord; 2009 Jul; 116(1-2):117-20. PubMed ID: 19054569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF 5-HIAA and DST non-suppression--orthogonal biologic risk factors for suicide in male mood disorder inpatients.
    Jokinen J; Nordström AL; Nordström P
    Psychiatry Res; 2009 Jan; 165(1-2):96-102. PubMed ID: 19062105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients.
    Jokinen J; Nordström P
    Psychoneuroendocrinology; 2008 Nov; 33(10):1387-93. PubMed ID: 18805641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients.
    Jokinen J; Nordström P
    J Affect Disord; 2009 Jul; 116(1-2):88-92. PubMed ID: 19054568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF 5-HIAA and DST non-suppression -independent biomarkers in suicide attempters?
    Jokinen J; Mårtensson B; Nordström AL; Nordström P
    J Affect Disord; 2008 Jan; 105(1-3):241-5. PubMed ID: 17499856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide.
    Jokinen J; Nordström AL; Nordström P
    J Affect Disord; 2008 Feb; 106(1-2):145-52. PubMed ID: 17662471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenergic function and HPA axis dysregulation in suicidal behaviour.
    Jokinen J; Ouda J; Nordström P
    Psychoneuroendocrinology; 2010 Nov; 35(10):1536-42. PubMed ID: 20576361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dexamethasone suppression test and suicide].
    Van Wettere JP; Charles G; Wilmotte J
    Acta Psychiatr Belg; 1983; 83(6):569-78. PubMed ID: 6673520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test and suicide prediction.
    Coryell W; Schlesser M
    Am J Psychiatry; 2001 May; 158(5):748-53. PubMed ID: 11329397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder.
    Coryell W; Young E; Carroll B
    Psychiatry Res; 2006 May; 142(1):99-104. PubMed ID: 16631257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dexamethasone suppression test repeated after a suicide attempt].
    Wilmotte J; Van Wettere JP; Depauw Y; Charles G
    Acta Psychiatr Belg; 1986; 86(3):242-8. PubMed ID: 3751647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary cortisol and suicidal behavior--a follow-up study.
    Lindqvist D; Isaksson A; Träskman-Bendz L; Brundin L
    Psychoneuroendocrinology; 2008 Sep; 33(8):1061-8. PubMed ID: 18672335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attempted suicide predicts suicide risk in schizophrenia spectrum psychosis.
    Carlborg A; Jokinen J; Nordström AL; Jönsson EG; Nordström P
    Nord J Psychiatry; 2010; 64(1):68-72. PubMed ID: 19883197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test and completed suicide.
    Norman WH; Brown WA; Miller IW; Keitner GI; Overholser JC
    Acta Psychiatr Scand; 1990 Feb; 81(2):120-5. PubMed ID: 2327273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test and ECT outcome: a six-month follow-up.
    Coryell W; Zimmerman M
    Biol Psychiatry; 1983 Jan; 18(1):21-7. PubMed ID: 6830923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal differences between psychotic and non-psychotic melancholic depression.
    Contreras F; Menchon JM; Urretavizcaya M; Navarro MA; Vallejo J; Parker G
    J Affect Disord; 2007 Jun; 100(1-3):65-73. PubMed ID: 17098292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression.
    Yerevanian BI; Feusner JD; Koek RJ; Mintz J
    J Affect Disord; 2004 Dec; 83(2-3):103-8. PubMed ID: 15555702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone suppression test and treatment response.
    Gitlin MJ; Gwirtsman H; Fairbanks L; Sternbach HA; Cedars PI; Gerner RH
    J Clin Psychiatry; 1984 Sep; 45(9):387-9. PubMed ID: 6469923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test in depressed patients: clinical and biochemical aspects.
    Holsboer F
    J Steroid Biochem; 1983 Jul; 19(1A):251-7. PubMed ID: 6887861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.